Akèy › Glomerilonefrit mbranè
Etid klinik pou Glomerilonefrit mbranè ap rekrite nan Etazini
7 etid pou Glomerilonefrit mbranè ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Ann Arbor, MI3 etid
- Miami, FL3 etid
- Cleveland, OH3 etid
- New York City, NY3 etid
- Philadelphia, PA3 etid
- Durham, NC3 etid
- Spokane, WA3 etid
- Baltimore, MD3 etid
- Washington, DC3 etid
Pa eta
- Florid3 etid
- Kalifòni3 etid
- Maryland5 etid
- Michigan3 etid
- Missouri3 etid
- New York3 etid
- North Carolina3 etid
- Ohio3 etid
- Pennsylvania3 etid
- Washington3 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
A Phase 3 Study of Inebilizumab in Participants With Primary Membranous Nephropathy
Ap rekriteFaz 3
Laj 18 a 79 · Tout sèks · Mizajou Oct 1, 2026 · NCT07851220An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Podocyte Diseases
Ap rekriteFaz 2
Laj 18 a 115 · Tout sèks · Mizajou Oct 1, 2026 · NCT06664814Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
Ap rekriteFaz 2
Laj 18 a 90 · Tout sèks · Mizajou Sep 22, 2026 · NCT00977977Belimumab With Rituximab for Primary Membranous Nephropathy
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 18, 2026 · NCT03949855NEPTUNE Match Study
Ap rekrite
Laj 1 a 80 · Tout sèks · Mizajou Jun 10, 2026 · NCT04571658Nephrotic Syndrome Study Network
Ap rekriteEtid obsèvasyon
Jiska laj 80 · Tout sèks · Mizajou Jun 10, 2026 · NCT01209000Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.
Ap rekriteEtid obsèvasyon
Laj 2 ak plis · Tout sèks · Mizajou Dec 22, 2025 · NCT05505500Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.